Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

Biotech stocks returned up to 36% in 2025, while longevity investing hit $8.5B in funding. Here’s the data individual ...

Dealmaking is back with a vengeance in the pharmaceutical sector this year. According to a report by PwC, there were more than $65 billion in pharma and life sciences mergers & acquisitions in the ...

The pharmaceutical sector differs from many industries as stock performance often depends less on near-term results and more on the success of products in development. For biotech companies, clinical ...

I'm messing with you, I know you would rather watch your parents kiss than listen to another monologue about tokens and data ...

Celldex Therapeutics, Inc. (NASDAQ:CLDX) is one of the best biotech stocks on this list. TheFly reported on June 10 that UBS increased its price target on CLDX to $45 from $38 while maintaining a Buy ...

Three biotech stocks in the IBD 50 are setting up in bases while a fourth is pulling back from highs as the first-quarter earnings season gets into full swing. Travere TherapeuticsTVTX, part of IBD's ...

Investing in up-and-coming stocks means having an appetite for risk, as this approach often involves chasing the latest Wall Street buzz. For instance, right now, some of the highest fliers are ...

Global biotech firms are increasingly being drawn to Hong Kong for its growing investor base and proximity to Chinese pharmaceutical partners.

Legend Biotech has frequently been at the center of takeover rumors, and the stock regularly spikes on speculation that it has received formal buyout bids. It stands out as one of the most uniquely ...